John E. Janik

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

James N. Kochenderfer, Wyndham H. Wilson, John E. Janik et al. · Blood · 2010 · 1.3K citations · Full text

Medicine, Hematology, Oncology +14

Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting

Kunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi et al. · Journal of Clinical Oncology · 2008 · 550 citations · Full text

Medicine, Immunology, Oncology +15

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman et al. · Blood · 2009 · 500 citations · Full text

Medicine, Oncology, Pharmacology +16

Brentuximab Vedotin (SGN-35)

Jessica Katz, John E. Janik, Anas Younes · Clinical Cancer Research · 2011 · 363 citations

Medicine, Oncology, Pharmacology +16

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

Upendra P. Hegde, Armando Filie, Richard F. Little et al. · Blood · 2004 · 353 citations · Full text

Medicine, Hematology, Oncology +12